Hong Woo Taik, Kim JIye, Kim Sug Won
Department of Plastic and Reconstructive Surgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
Arch Craniofac Surg. 2019 Aug;20(4):246-250. doi: 10.7181/acfs.2019.00059. Epub 2019 Aug 20.
Recently, there is a growing interest of hyperbaric oxygen therapy in many fields of medicine. We had a 43-year-old female patient presented with severe necrosis of the nose, philtrum, and upper lip due to retrograde arterial occlusion after nasolabial fold hyaluronic acid filler injection. Our patient went through 43 sessions of systemic hyperbaric oxygen therapy from December 2, 2017 to January 18, 2018. We administered 2.8 atmosphere absolute (ATA) for 135 minutes in the first session and the remaining sessions consisted of 2.0 ATA for 110 minutes. In reporting this case, we wish to provide a warning regarding the latent risk of filler injections and share our experience about minimizing soft tissue damage in the early stages with systemic hyperbaric oxygen therapy.
近年来，高压氧疗法在医学诸多领域的应用越来越受到关注。我们有一位43岁的女性患者，在鼻唇沟注射透明质酸填充剂后因逆行性动脉闭塞，导致鼻子、人中及上唇严重坏死。该患者于2017年12月2日至2018年1月18日接受了43次全身高压氧治疗。第一次治疗时，我们给予2.8个绝对大气压（ATA），持续135分钟，其余治疗均为2.0 ATA，持续110分钟。在报告该病例时，我们希望就填充剂注射的潜在风险发出警示，并分享我们在早期通过全身高压氧治疗将软组织损伤降至最低的经验。
